- Medicina Experimental
Departament
![Foto de - Medicina Experimental](/img/noimage.png)
![Foto de Centro de Investigación Biomédica en Red de Cáncer](/img/noimage_org.png)
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red de Cáncer (12)
2024
-
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review
Cancers, Vol. 16, Núm. 1
2023
-
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers
Advanced Science, Vol. 10, Núm. 32
-
Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness
Molecular Oncology, Vol. 17, Núm. 1, pp. 98-118
-
Protocol to characterize the melanoma tumor immune microenvironment in mice from single cell to flow cytometry analysis
STAR Protocols, Vol. 4, Núm. 4
-
Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis
Cancer Communications
2022
-
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma
Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259
-
M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors
British Journal of Cancer
-
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer
Cancers, Vol. 14, Núm. 12
2019
-
Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis
Journal of Pathology, Vol. 247, Núm. 1, pp. 72-85
2017
-
A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium
Cell Death and Differentiation, Vol. 24, Núm. 8, pp. 1443-1458
-
Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias
Journal of Pathology, Vol. 242, Núm. 2, pp. 152-164
-
Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients
Oncotarget, Vol. 8, Núm. 65, pp. 109018-109026